AI assistant
Sending…
Celldex Therapeutics, Inc. — Director's Dealing 2010
Sep 9, 2010
31801_dirs_2010-09-09_2f756aed-5c8c-45a1-860d-234a9e93bcc4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2010-09-09
Reporting Person: PENNER HARRY JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-09-09 | Common Stock | P | 3000 | $3.49 | Acquired | 3000 | Direct |
More from Celldex Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 2
Capital/Financing Update
2026
Apr 2
Capital/Financing Update
2026
Apr 1
Major Shareholding Notification
2026
Mar 26